3-87227421-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014043.4(CHMP2B):​c.-102C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,405,614 control chromosomes in the GnomAD database, including 151 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0095 ( 11 hom., cov: 32)
Exomes 𝑓: 0.013 ( 140 hom. )

Consequence

CHMP2B
NM_014043.4 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0420

Publications

3 publications found
Variant links:
Genes affected
CHMP2B (HGNC:24537): (charged multivesicular body protein 2B) This gene encodes a component of the heteromeric ESCRT-III complex (Endosomal Sorting Complex Required for Transport III) that functions in the recycling or degradation of cell surface receptors. ESCRT-III functions in the concentration and invagination of ubiquitinated endosomal cargos into intralumenal vesicles. The protein encoded by this gene is found as a monomer in the cytosol or as an oligomer in ESCRT-III complexes on endosomal membranes. It is expressed in neurons of all major regions of the brain. Mutations in this gene result in one form of familial frontotemporal lobar degeneration. [provided by RefSeq, Jul 2008]
CHMP2B Gene-Disease associations (from GenCC):
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • amyotrophic lateral sclerosis type 17
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 3-87227421-C-T is Benign according to our data. Variant chr3-87227421-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 346802.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00952 (1450/152336) while in subpopulation NFE AF = 0.0158 (1078/68024). AF 95% confidence interval is 0.0151. There are 11 homozygotes in GnomAd4. There are 679 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1450 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHMP2BNM_014043.4 linkc.-102C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 6 ENST00000263780.9 NP_054762.2
CHMP2BNM_014043.4 linkc.-102C>T 5_prime_UTR_variant Exon 1 of 6 ENST00000263780.9 NP_054762.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHMP2BENST00000263780.9 linkc.-102C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 6 1 NM_014043.4 ENSP00000263780.4
CHMP2BENST00000263780.9 linkc.-102C>T 5_prime_UTR_variant Exon 1 of 6 1 NM_014043.4 ENSP00000263780.4

Frequencies

GnomAD3 genomes
AF:
0.00953
AC:
1450
AN:
152220
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0155
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0158
Gnomad OTH
AF:
0.00813
GnomAD4 exome
AF:
0.0125
AC:
15691
AN:
1253278
Hom.:
140
Cov.:
18
AF XY:
0.0123
AC XY:
7773
AN XY:
633156
show subpopulations
African (AFR)
AF:
0.00164
AC:
48
AN:
29242
American (AMR)
AF:
0.00443
AC:
194
AN:
43768
Ashkenazi Jewish (ASJ)
AF:
0.00478
AC:
118
AN:
24688
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38546
South Asian (SAS)
AF:
0.00209
AC:
171
AN:
81750
European-Finnish (FIN)
AF:
0.0189
AC:
993
AN:
52440
Middle Eastern (MID)
AF:
0.000932
AC:
5
AN:
5364
European-Non Finnish (NFE)
AF:
0.0148
AC:
13639
AN:
924130
Other (OTH)
AF:
0.00980
AC:
523
AN:
53350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
778
1556
2334
3112
3890
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00952
AC:
1450
AN:
152336
Hom.:
11
Cov.:
32
AF XY:
0.00912
AC XY:
679
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00224
AC:
93
AN:
41588
American (AMR)
AF:
0.00470
AC:
72
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
0.0155
AC:
165
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0158
AC:
1078
AN:
68024
Other (OTH)
AF:
0.00805
AC:
17
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
75
150
226
301
376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00639
Hom.:
3
Bravo
AF:
0.00804
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 10, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
9.0
DANN
Benign
0.88
PhyloP100
0.042
PromoterAI
-0.019
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36098294; hg19: chr3-87276571; COSMIC: COSV55461752; COSMIC: COSV55461752; API